Butylphthalide soft capsule and ginkgo biloba can be taken together when there is a therapeutic need.
Butylphthalide soft capsule is usually used for the treatment of mild and moderate acute ischemic stroke; Ginkgo biloba’s main ingredient is ginkgo biloba extract, which has the efficacy of activating blood circulation, removing blood stasis and opening up the channels, and can be used for chest paralysis and heart pain caused by blood stasis and blood blockage and stroke, and also for the above symptoms caused by cerebral infarction.
The ingredients of the two drugs will not interact with each other and adversely affect the body, and can be taken together.
Adverse reactions such as transient elevation of aminotransferase and nausea may occur after taking butylphthalide, and it is forbidden for patients who are allergic to the components of this product or have serious bleeding tendency; the adverse reactions and contraindications of ginkgo biloba are not clear.
It is recommended that patients with related diseases consult professional hospitals, under the guidance of physicians for related treatment, and strictly comply with medical advice.